Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

KRBP
Kiromic BioPharma Inc
stock NASDAQ

At Close
1/27/2023 3:59:30 PM EST
0.1985USD+2.320%(+0.0045)16,502,202
0.1572Bid   0.2394Ask   0.0822Spread IEX
Pre-market
1/27/2023 9:13:30 AM EST
0.1896USD-2.268%(-0.0044)0
After-hours
1/27/2023 4:03:30 PM EST
0.1950USD-1.763%(-0.0035)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
3.144M
Headquarters
Houston, Texas, USA
Industry
Biotechnology
KRBP Stats
Avg. Vol. 10 Day
1,192,448
Avg. Vol. 30 Day
515,589
Employees
60
Market Cap
3,144,064
Shares Out.
15,839,112
Float
11,875,694
On/Off Exchange
48%/52%
6 Month Beta
0.44
1 Year Beta
0.91
2 Year Beta
1.00
3 Year Beta
0.96
52 Week Low
0.15
52 Week High
1.18
SMA50
0.21
SMA200
0.31
1 Week
-4.29%
1 Month
+28.07%
3 Month
-32.62%
6 Month
-38.92%
1 Year
-79.75%
2 Year
-97.79%
Nov 24, 2021
04:25PM EST  Kiromic BioPharma Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q   Benzinga
Oct 25, 2021
07:12AM EDT  Kiromic BioPharma Announces Results Of Phase 1 Trial Of KiroVax/BSK01 Cell Therapy Cancer Vaccine Candidate In Combinatin With Chemotherapy; Showed Progression Free Survival Of 7 Months After Treatment vs 3.9 Months With Standard Care   Benzinga
Oct 12, 2021
08:13AM EDT  The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology   Benzinga
Oct 11, 2021
08:05AM EDT  Kiromic BioPharma Announces Strategic Collaboration With Gemelli Teaching Hospital To Accelerate The Analysis Of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 In Solid Cancers   Benzinga
Oct 7, 2021
08:24AM EDT  The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results   Benzinga
More News
Profile
Kiromic BioPharma, Inc. is an immuno-oncology biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology applications through its robust product pipeline. The pipeline development is leveraged through the Company's proprietary target discovery engine called 'DIAMOND.' Kiromic's DIAMOND is essentially big data science meeting target identification, dramatically compressing the man-years and the millions of drug development dollars needed to develop a live drug. The Company's headquarters are located in Houston, TX adjacent to the world's largest medical center and the MD Anderson Cancer Center.

KRBP Stock Summary

Kiromic BioPharma Inc (NASDAQ:KRBP) stock price today is $0.1985, and today's volume is 16,502,202. KRBP is up 2.320% today. The 30 day average volume is 515,589. KRBP market cap is 3.144M with 15,839,112 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC